AUSTIN, Texas, June 11, 2014 (GLOBE NEWSWIRE) —, Inc. announced today that a new audio interview with PositiveID Corporation (“PositiveID” or the “Company”) (OTCQB:PSID), a developer of biological detection and diagnostics solutions, is now available. The interview can be heard at

PositiveID’s Chairman and Chief Executive Officer, William J. Caragol, called in to to discuss the Company’s recent announcement of its first-ever revenue guidance of $4-10 million, $3.3 million of which is already in backlog, over the next 18 months. During the interview Mr. Caragol also describes how a pick-up in U.S. government bio-threat detection research and development as well as procurements are providing the Company with increased business opportunities. is a recognized corporate investor relations firm, with clients nationwide, known for its ability to help emerging growth companies build a following among retail and institutional investors. utilizes its stock newsletter to feature its daily stock picks, audio interviews, as well as its clients’ financial news releases. also offers individual investors all the tools they need to make informed decisions about the stocks they are interested in. Tools like stock charts, stock alerts, and Company Information Sheets can assist with investing in stocks that are traded on the OTC BB and Pink Sheets. To learn more about and their services, please visit

About PositiveID Corporation

PositiveID Corporation is an emerging growth company and developer of biological detection systems for America’s homeland defense industry as well as rapid biological testing. PositiveID is focused on the development of microfluidic systems for the automated preparation of and performance of biological assays in order to detect biological threats and analyze biological samples. For more information on PositiveID, please visit

Statements about PositiveID’s future expectations, including without limitation, the likelihood that PositiveID will generate revenue of $4-10 million, $3.3 million of which is already in backlog, over the next 18 months; constitute “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and as that term is defined in the Private Litigation Reform Act of 1995. Such forward-looking statements involve risks and uncertainties, including the likelihood that PositiveID will be successful with its submissions for bids and proposals in response to a pick-up in new U.S. government procurements for bio-threat detection, and are subject to change at any time, and PositiveID’s actual results could differ materially from expected results. Additional information about these and other factors that could affect the Company’s business is set forth in the Company’s various filings with the Securities and Exchange Commission, including those set forth in the Company’s 10-K filed on April 11, 2014, and 10-Qs filed on May 20, 2014, November 19, 2013, and August 14, 2013, as amended August 19, 2013, under the caption “Risk Factors.” The Company undertakes no obligation to update or release any revisions to these forward-looking statements to reflect events or circumstances after the date of this statement or to reflect the occurrence of unanticipated events, except as required by law.

PositiveID Corporation
Allison Tomek

Contact for

Stuart T. Smith